Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

PAK4 inhibition can sensitize tumors to immune checkpoint blockade (ICB) therapy; however, the underlying mechanisms remain unclear. We report that PAK4 inhibition reverses immune cell exclusion by increasing the infiltration of CD8 T cells and CD103(+) dendritic cells (DC), a specific type of DCs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abril-Rodriguez, Gabriel, Torrejon, Davis Y., Karin, Daniel, Campbell, Katie M., Medina, Egmidio, Saco, Justin D., Galvez, Mildred, Champhekar, Ameya S., Perez-Garcilazo, Ivan, Baselga-Carretero, Ignacio, Singh, Jas, Comin-Anduix, Begoña, Puig-Saus, Cristina, Ribas, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799984/
https://www.ncbi.nlm.nih.gov/pubmed/36588582
http://dx.doi.org/10.1158/2767-9764.CRC-21-0133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799984/
https://www.ncbi.nlm.nih.gov/pubmed/36588582
http://dx.doi.org/10.1158/2767-9764.CRC-21-0133

Ejemplares similares